Metabonomic analysis has been widely used in the study of traditional Chinese medicine (TCM) syndromes.
Introduction
Traditional Chinese Medicine (TCM), which has contributed to disease management in Chinese populations and Asia for over 3000 years, is currently considered to be a complementary or alternative medical system in most Western countries.
1
Different from modern medicine, TCM regards the syndrome (Zheng in Chinese) as the core concept for understanding a disease. TCM syndromes concern the origin, cause and features of a disease and the conicts between the healthy state and pathogens, aiming to reveal the intrinsic quality of a disease completely and accurately. 2 The TCM diagnosis and treatments are based on differentiation of the TCM syndrome with the data collected through any combination of four diagnostic methods (inspection, auscultation and olfaction, inquiry, and palpation).
3 Therefore, a correct understanding and differentiation of TCM syndromes determines the effectiveness of TCM therapy using Chinese herbal formulae. Recently, TCM syndromes were detected and veried in some diseases under Western medicine's demarcation, including postmenopausal osteoporosis, 4 gastric mucosal dysplasia, 5 coronary heart disease, 6 etc. Meanwhile, TCM syndromes were applied for the classication and diagnosis of some complicated diseases, such as rheumatoid arthritis, 7 diabetes, 8 etc. Accordingly, elucidating the modern connotation of TCM syndromes will benet the objectication of TCM diagnosis and treatment, and also promote the application of integrated TCM and Western medicine in the treatment of complex diseases.
Due to the holistic and dynamic characteristics, the research principle of reductionism is not suitable for exploring the scientic basis of TCM syndromes. Metabonomic analysis, a systems biology approach, adopts a 'top-down' strategy to reect the function of organisms from the terminal symptoms of the metabolic network and to understand the metabolic changes of a complete system caused by interventions in the holistic context. 2 This method is similar to the views of the holistic approaches, syndromes, and syndrome differentiation of TCM. Therefore, metabonomics analysis has been widely used in the study of TCM syndromes. However, the current studies, without considering both the dynamic and holistic characteristics, only obtain differential metabolites at different time points during the syndrome evolution or the metabolic network at a certain stage of TCM syndrome. The global metabolic changes associated with the development of the syndrome are not claried. For example, Shang et al. investigated the plasma metabolic characteristics of the rat model of blood heat and hemorrhage syndrome based on the UHPLC/Q-TOF MS platform, in order to gain more understanding of the possible bleeding mechanism of blood heat and hemorrhage syndrome. 9 Qiu et al. used time course plasma metabonomics analysis to investigate the material basis of the development of qi deciency/qi deciency and blood stasis syndromes in myocardial infarction induced heart failure rats. 3 Wang et al. studied the mechanism of the hot syndrome through urine metabonomics, 10 and Chen et al. investigated metabolite changes of serum samples through metabonomic approaches in a Kidney-Yang deciency syndrome rat model.
11
In this paper, the stage division and dynamic changes of the metabolic network during syndrome evolution in the toxic heat and blood stasis syndrome (THBSS) rat model have been studied for the rst time. THBSS originated from Synopsis of Golden Chamber and is a common severe TCM syndrome shown in a variety of infectious diseases, acute diseases, chronic diseases and critical diseases such as acute nephritis, multiple organ failure syndrome, sepsis, pneumonia, coronary heart disease, and systemic lupus erythematosus. 12 Previous studies indicate that the pathogenesis of THBSS is complex and involves multiple factors, including the release of proinammatory mediators, injury of endothelial cells, hemodynamic abnormity, microcirculation disturbance and platelet dysfunction. 13 Although several factors have been proposed to be involved in the progression of THBSS, the systemic and characteristic metabolic alterations involved in the development of THBSS remain unclear. Meanwhile, there are no standard diagnostic criteria consistent with modern medicine for THBSS, which further limits the application of TCM in the treatment of THBSS-related diseases. So the elucidation of its holistic and dynamic metabolic alterations is critical to understand its pathogenesis and identify potential biomarkers and drug targets.
The TCM syndrome model is the basic tool to study the dynamic development and reveal the essence of TCM syndromes. Based on TCM theory, the pathogenesis of THBSS is that heat-toxins invade the body and burn blood vessels causing the insufficiency of liquid and blood, and then blood stasis occurs. Thus, heat-toxins are the key pathogenic factor. Recently, bacteria (such as Pseudomonas aeruginosa), viruses (such as inuenza virus) and endotoxins (such as lipopolysaccharide) have been used as pathogenic heat-toxins. However, bacteria and viruses easily lead to animal death, causing the failure of modeling.
14 Xu et al. reported that plasma endotoxin does have an inner link with THBSS. 15 So lipopolysaccharides (LPSs) are commonly used as heat-toxin materials to establish the THBSS model. Among different kinds of LPS-based modeling methods, Liang et al. use LPSs in combination with carrageenan (CAR) to develop a TCM syndrome of THBSS in rats. This model integrated syndrome (THBSS) and disease (thrombosis) has several advantages: (1) it can reect the THBSS manifestation accurately; (2) based on the tail thrombosis, it is convenient to estimate whether the model is successful or not; (3) it is also easily practicable, repeatable and highly consistent so it is suitable for metabonomics research.
16
To comprehensively prole the changes in metabolite levels associated with the progression of THBSS, we used the THBSS rat model, a well-established animal model by Liang, 16 and investigated whether the rat model showed progression of THBSS based on biochemical parameters and TCM syndrome diagnostic criteria. With the goals of discovering specic biomarkers of syndrome progression, identifying perturbed metabolic pathways associated with the pathogenesis of the syndrome, and discovering potential drug targets, time course urine metabonomics analysis based on UPLC/Q-TOF MS with pattern recognition technology and principal component analysis was performed to study the metabolic alterations in the urine obtained from the THBSS model rats.
Material and methods

Materials
Lipopolysaccharide (lot no. 095M4164V) and carrageenan (lot no. SLBK3896V) were obtained from Sigma-Aldrich (St. Louis, MO, USA). Leucine-enkephalin (lot no. MB11442) was obtained from BSCX Technology Co., Ltd (Beijing, China). Methanol and acetonitrile were of HPLC grade and purchased from Merck Group (Darmstadt, Germany); HPLC grade formic acid was purchased from Fisher Scientic Corporation (Loughborough, UK). Ultra-high purity water (18.2 MU, TOC < 5 ppb) was prepared by a Millipore Milli-Q Integral 3 Ultrapure Water System (Billerica, MA, USA). The blood coagulation function assay kits were purchased from Sysmex Corporation (Kobe, Japan). TNF-a (lot no. E-EL-R0019c), IL-6 (lot no. E-EL-R0015c) and IL-1b (lot no. E-EL-R0012c) assay kits were purchased from Elabscience Biotechnology Co., Ltd (Wuhan, China).
Animals and treatments
Sixty-eight male Sprague-Dawley rats (180-200 g) were purchased from the Experimental Animal Center of Peking University Health Science Center (Beijing, China) on October 25, 2015 and kept at a standard temperature (23 AE 2 C) and humidity (60 AE 5%) in a controlled room with a light/dark cycle of 12 h for a week. During this period animals were allowed free access to food and water. Prior to each experiment, the rats were fasted for 12 h with free drinking. Among them, 48 rats were used for evaluation of the THBSS stage and randomly divided into 6 groups named the 2 h control group (2 h CG), 2 h THBSS group (2 h TG), 8 
Sample collection and preparation
Rats in the control and THBSS groups of 2 h, 8 h, 24 h were anesthetized with 10% chloral hydrate at 2 h, 8 h and 24 h aer modeling respectively. Then 6 mL blood obtained with the heart puncture technique was collected into one 2 mL sodium citrate vacuum blood collection tube (SCVBCT) and two 2 mL EDTA vacuum blood collection tubes (EVBCTs). The blood sample in one of the EVBCTs stood at room temperature (22) (23) (24) (25) C) for 30 min. The blood samples in the SCVBCT and the other EVBCT were centrifuged at 3000 rpm for 10 min to get the plasma and stored at À80 C until the biochemical analysis. In addition, the liver and lung tissues were dissected for histological examination.
The urine samples of rats used for the metabonomics analysis were collected before administration (denoted as urine samples of 0 h) and at the time-points of 2, 5, 8, 12, 24, 36 and 48 h aer administration. Each urine sample was rst centrifuged at 14 000 rpm for 10 min at 4 C, and the supernatant was ltered through a 0.22 mm lter membrane and stored at À80 C until the LC-MS experiments.
Evaluation of the THBSS stage
The Before modeling, the rats' forehead temperatures were measured three times a day by a digital thermometer (OMRON Co. Ltd., MC-347) for monitoring the regular rhythm of the forehead temperatures. The rats with temperature variances that were greater than 0.5 C were excluded. The temperature variance of all the rats in our experiment met the requirement. Moreover, the forehead temperatures of the rats in the 24 h CG and 24 h TG were determined at 2 h, 4 h, 5.5 h, 7 h, 8 h, 9.5 h, 12 h, 16 h and 24 h aer modeling. Blood biochemical parameters. The plasma obtained from the EVBCT was used to assay levels of IL-6, TNF-a and IL-1b by ELISA kits according to the manufacturers' instruction. The plasma obtained from the SCVBCT was used to test the TT, PT and APTT with a Sysmex CA-500 automatic blood coagulation analyzer (Sysmex Corporation, Kobe, Japan). In addition, 800 mL anticoagulant blood in the EVBCT was used to determine the whole blood viscosity with a BT-300 Automated Viscometer (Nanjing Zhilun Electronic Technology Co., Ltd, Nanjing, China).
Histological examination. The liver and lung were xed in 10% (v/v) formalin for at least 24 h. Then they were embedded in paraffin wax, processed to 3 mm sections, stained with hematoxylin and eosin (H-E) and were observed under a light microscope (Olympus Corporation, OLYMPUS CX21).
Metabonomics analysis
Urine sample preparation. Prior to UPLC-MS analysis, the urine samples were thawed at room temperature (22) (23) (24) (25) C), diluted at a ratio of 2 : 1 (v/v) using ultra high purity water, vortex mixed and centrifuged at 14 000 rpm for 10 min at 4 C.
The supernatants were subjected to the UPLC Q-TOF/MS system for analysis. A pooled "quality control" (QC) sample was prepared by mixing equal aliquots (10 mL) from all urine samples for the optimization of the chromatographic and TOF/ MS conditions, and method validation. UPLC/Q-TOF MS conditions. The analysis was performed using a Waters Acquity™ Ultra Performance LC system (Waters Corp., Milford, MA) connected to a Xevo™ G2-Q-TOF mass spectrometer (Waters MS Technologies, Manchester, UK). Separation was performed on a Waters HSS T3 column (2.1 mm Â 100 mm, 1.8 mm) kept at 50 C and at a ow rate of 0.3 mL min
À1
. The gradient mobile phase was a mixture of 0.1% formic acid in water (A) and acetonitrile (B). The gradient elution of B was performed as follows: 0-1.5 min, 0% B; 1.5-6.5 min, 0-20% B; 6.5-10 min, 20-40% B; 10-11 min, 40-100% B; 11.1-12.5 min, 100-0% B. 3 mL of the sample solution was injected for each run. During the whole analysis, all the samples were maintained at 4 C. The electrospray ionization (ESI) source was operated in the positive and negative modes. The prole data from m/z 50-1200 were recorded. Nitrogen gas was used as the cone and desolvation gas. The desolvation gas was set at 800 L h À1 at a temperature of 400 C, the cone gas was set at 25 L h
, and the source temperature was set at 100 C. In the positive ion mode, the capillary and cone voltages were 3.0 kV and 40 V, respectively. In the negative ion mode, the capillary and cone voltages were 2.3 kV and 40 V, respectively. All of the data were acquired using the lockspray to ensure accuracy and reproducibility. Leucine enkephalin was used as the lockmass at a concentration of 1500 ng mL À1 and a ow rate of 5 mL min
. MS E technology was used for the data collection with the low collision energy of 6 eV and the high collision energy ramp of 20-40 eV. Urine samples analysis. As the QC sample contained the most information of all the urinary samples, it was used to monitor the consistency of the UPLC/Q-TOF MS system. Prior to analysis, the QC sample ran six times rst to test the stability of the instrument. During the analytical run the QC sample was injected every ten experimental samples to monitor the system consistency.
Data analysis. The UPLC/Q-TOF MS raw data les of the urine samples were processed with the Progenesis QI soware (version 2.0, Waters, Milford, MA, USA), which can detect the mass, retention time and intensity of peaks in each chromatogram. Aer data pretreatment of the MS E data, the 3D LC-MS raw data were converted into a 2D matrix with the Retention Time-Exact Mass (RTEM) pair and peak intensity as the variable and observation ID, respectively. The t-test and fold change analysis were conducted by Progenesis QI; the ltered data (P < 0.05 and the value of fold change >2) containing 541 ions (positive mode) and 799 ions (negative mode) were processed for principal component analysis (PCA), orthogonal partial least squares discriminant analysis (OPLS-DA) and partial least squares discriminant analysis (PLS-DA) by the SIMCA-P so-ware (version 13.0, Umetrics, Umea, Sweden) respectively. PCA and PLS-DA models were constructed to disclose the urinary metabolites trajectory of different period rats. The OPLS-DA was used to screen the potential biomarkers. The Venn diagram was created using a free web-based Venn diagram generating resource (http://bioinfogp.cnb.csic.es/tools/venny) to select property-related ions.
The following databases were used to identify the potential biomarkers: HMDB (http://www.hmdb.ca/), KEGG (http:// www.genome.jp/kegg/), Mass-bank (http://www.massbank.jp) and METLIN (http://metlin.scripps.edu/). The pathway analysis was performed with metabolomics pathway analysis (MetPA) (http://www.metaboanalyst.ca).
Results
Syndrome diagnosis and model conrmation
Physical signs. There were no obvious THBSS manifestations or signicant variance observed in the rats of all control groups. However, the rats of the model groups at different time points exhibited different physical signs. In the 2 h TG, the rats expressed listlessness (squinted eyes, towered hair, and group bundling) and had elevated forehead temperature (the value was 37.51 AE 0.54 C and located in the ascending part of the temperature curve) and red paws and ears, but normal tails. In the 8 h TG, the rats had normal mental status (squinting and other symptoms disappeared) and slightly higher forehead temperature (the value was 37.50 AE 0.48 C and located in the descending part of the temperature curve), light red paws and ears, and short thrombi in tails (mean: 2.56 cm; range: 0-6.4 cm). In the 24 h TG, the rats had normal mental status (no squinting and other symptoms), normal forehead temperature (36.51 AE 0.11 C) and light purple paws and ears, but the thrombosis length in the tail increased (mean: 7.01 cm; range: 1.8-11.7 cm) (Tables S1, S2 Cytokines and blood biochemical parameters. The results of the TNF-a, IL-6 and IL-1b content are shown in Table 1 . Compared with the 0 h CG, the levels of TNF-a, IL-6 and IL-1b signicantly (P < 0.05) increased in the 2 h TG, and were the maximum value among all time points. Meanwhile, the content of TNF-a, IL-6 and IL-1b in TG decreased to normal over time. In comparison with those of the 0 h CG, the levels of IL-6 and IL-1b in the 24 h TG showed no signicant difference (P > 0.05).
Compared to the CG, the whole blood viscosity signicantly (P < 0.05) increased in the TGs at different time points. Meanwhile, the whole blood viscosity variation trend of rats in the TGs was: 24 h TG > 8 h TG > 2 h TG (Table 2) .
Compared to the corresponding CGs, APTT signicantly (P < 0.05) prolonged in the 2 h TG; PT, TT and APTT all signicantly (P < 0.05) prolonged in the 8 h TG; PT highly signicantly decreased (P < 0.01), and APTT and TT still signicantly (P < 0.05) prolonged in the 24 h TG (the difference with CG was reduced) (Table 3) .
It has been reported that the elevation of TNF-a and IL-6 are biochemical indexes of excessive heat syndrome. 17 The elevation of whole blood viscosity and abnormal coagulation indices are biochemical indexes of blood stasis syndrome. These results indicated that excessive heat syndrome was becoming less signicant, but blood stasis syndrome became more and more obvious over time.
Histological examination. Fig. 1 and 2 show representative images of the histological examination of hematoxylin-eosin (H-E)-stained sections of lungs and livers, respectively, from control and model rats at different time points. The pathological results of the lung tissues showed that few red cells aggregated in the small pulmonary veins of rats in the 2 h TG; widened alveolar septum containing a few inammatory cells and some red cell aggregation in the small pulmonary veins were observed in the rats of the 8 h TG; in the 24 h TG, large numbers of red cells emerged in the small pulmonary veins and alveolar wall capillaries, and the alveolar space was lled with few red cells.
The pathological results of the liver tissues showed that the normal structure of hepatic lobules and liver cells with light edema were observed in the rats of the 2 h TG; liver cells with moderate edema and few red cells spreading in the liver sinus were observed in the rats of the 8 h TG; in the 24 h TG, structural disorder of hepatic lobules, liver cells with severe edema and red cells clustered in the hepatic sinus and central vein of hepatic lobules were observed. Based on these results, it could be concluded that the lung and liver tissue damage and congestion were aggravated with time.
A combination of syndrome classication and biochemical indexes becomes a common model in TCM diagnostics in both clinical and nonclinical practice. Consequently, based on the three aspects above, the syndrome progression of the rat model was diagnosed. 2 h aer modeling, the rats were in the stage of excessive heat and little blood stasis (EHLBS); 8 h aer modeling, the rats were in the stage of the coexistence of heat and blood stasis (CHBS); 24 h aer modeling, the rats were in the stage of blood stasis (BS).
Metabonomics analysis
LC-MS spectra and pattern recognition analysis of urine samples. Compared with the urine samples at 0 h, there were signicant variances in the region of 0.5-2.0 min (more remarkable in positive ion mode) and 3.5-8.0 min (more Table 2 a Signicant differences were based on the two-tailed t-test. Compared with the corresponding CG, * represents the signicant differences (P < 0.05); ** represents the signicant differences (P < 0.01). Compared with the corresponding CG, * represents the signicant differences (P < 0.05); ** represents the signicant differences (P < 0.01). remarkable in negative ion mode) in the spectra of the urine collected from the model rats at 2 h, 12 h and 48 h. Nevertheless, both in positive and negative modes the LC-MS proling of the urine obtained from the control rats at 2 h, 12 h and 48 h showed no obvious alterations in metabolites (Fig. S2-S5 †) . The partial least squares discriminant analysis (PLS-DA) mean trajectory showed a characteristically different distribution in metabolic patterns between the control group and model group (the samples of the model group were distributed in the rst, second and fourth quadrant, whereas the samples of the control group were located only in the third quadrant) (Fig. 3) . Furthermore, results from the model groups revealed an obvious trajectory space from 2 h to 48 h, whereas the control groups occupied a narrow space in the plot, suggesting that the observed changes in the metabolic proles were mostly related to the progression of the syndrome.
Urine metabolic footprint analysis. To investigate the continuous metabolic changes throughout the experimental period in the model rats, which were manifestations of pathological insult, the PCA was rst used to give an overview of all urine samples and examine the intrinsic variation within the groups. The PCA models established had a satisfactory goodness of t (R These constructed metabolic trajectories were consistent with the results of the syndrome progression diagnosed based on the TCM criterion, which showed three stages: excessive heat and little blood stasis (2-5 h), coexistence of heat and blood stasis (8-12 h), and blood stasis (24-48 h). Selection and identication of the potential biomarkers. 2 h, 8 h and 24 h aer modeling were three typical time points in the progression of THBSS. To explore the associated differential metabolites of different syndrome stages, 2 h, 8 h and 24 h timepoint data were chosen to perform a supervised multivariate data analysis using OPLS-DA which would remove noncorrelated variations contained within the spectra (Fig. S6 †) . The OPLS-DA models established had a satisfactory goodness of t (R 2 X ¼ 0. characteristic fragment ions, the metabolites were tentatively identied. Through searching databases and spectra comparison, the structures of the metabolites were further conrmed. Finally, 64, 58 and 51 metabolites were identied respectively. For example, the ion at m/z 123.0553 (elemental composition: C 6 . This suggests that there are at least two carboxyl groups in the structure of M2. These data were consistent with those of isocitric acid, which was also supported by the HMDB database (Fig. S8 †) . Other metabolites were determined using the same method described above.
To further reveal potential biomarkers related to the syndrome progression, common features among the differential metabolites at different time points were selected using a Venn diagram (Fig. 7) . The trends in the change of the common metabolites of 8 h and 24 h, and 2 h and 24 h were different, but the trend in the change of the common metabolites of 2 h and 8 h was the same. Combined with the opposite distribution of 2 h and 24 h in the PCA plot (Fig. 4) , these results indicated that the metabolic disturbance of the excessive heat and little blood stasis stage (2 h) and blood stasis stage (24 h) are of opposing directionality. The Venn diagram showed 21 common metabolites at the three time points (Table S7 †) . Additionally, analysis of the temporal changes of these metabolites revealed that 7 metabolites, i.e., isocitric acid, glucose, 3-dehydroxycarnitine, N-a-acetylcitrulline, N-acetylglumine, iduronic acid and homocystein sulnic acid were in a consensus change trend with the syndrome progression. These characteristic changes could serve as potential biomarkers of THBSS. Except glucose, the other 6 metabolites were rstly reported as the potential biomarkers of blood stasis syndrome, among which homocystein sulnic acid was rstly regarded as a potential biomarker. The changes in potential biomarkers from the onset to the progression of THBSS are shown in Fig. 8 . Compared with the normal rats, the levels of several glucose metabolism intermediates (such as isocitric acid and glucose) were elevated in the samples collected from THBSS rats at 2 h, 5 h, 8 h and 12 h and reduced at 24 h, 36 h and 48 h. The levels of 3-dehydroxycarnitine related to b-oxidation of long-chain fatty acids down-regulated in the samples collected at 2 h, 5 h, 8 h and 12 h and up-regulated at 24 h, 36 h and 48 h. These changes indicate excessive energy consumption in the excessive heat and little blood stasis stage and the blockade of the energy metabolism. 19 The levels of N-acetylglutamine and N-a-acetylcitrulline, which are associated with nervous system functions, were elevated in the samples collected at 2 h, 5 h, 8 h and 12 h and reduced at 24 h, 36 h and 48 h, suggesting that the nervous system is disturbed in THBSS. 20, 21 The levels of iduronic acid and homocysteine sulnic acid, which can affect coagulation function, were altered, demonstrating the dysfunction of coagulation during THBSS progression.
22,23
Pathway analysis. Well-known changes in more important positions of a network will trigger a more severe impact on the pathway. 24 The pathway analysis was performed using MetaboAnalyst 3.0 (Table 4) . The results showing alterations in the metabolic pathways during the progression of THBSS are summarized in Fig. 9 . Nicotinamide and 1-methylnicotinamide were down-regulated, suggesting that the reduced nicotinate and nicotinamide metabolism activates the NF-kB pathway. The lower levels of 1-methylhistidine, urocanate and histidine indicate that the down-regulation of histidine metabolism causes the imbalance in the coagulation function. These metabolic changes and the associated pathways provide insights into the mechanisms involved in the development and progression of THBSS.
Discussion
Nicotinate and nicotinamide metabolism
In the present study, the signicantly decreased levels of nicotinamide (at 2 h, 8 h and 24 h) and 1-methylnicotinamide (at 2 h and 8 h) of the model group showed a hampered nicotinate and nicotinamide metabolism during the THSBB progression. Moreover, at 24 h only nicotinamide decreased, thus nicotinate and nicotinamide metabolism had a weak inhibition at this time point (Fig. 9 , Tables S3-S5 †).
It has been reported that nicotinamide is the main precursor of nicotinamide adenine dinucleotide (NAD + ) formed by transamination in vivo. NAD + as a sirtuin 1 (SIRT1) agonist may activate SIRT1 by regulating the ratio of NAD + /NADH. SIRT1 is [ represents up regulation; the impact is the pathway impact value calculated from the pathway topology analysis; "-" represents no metabolites related with the pathway obtained at this time-point. Fig. 8 Relative abundances of metabolites obtained from urine samples at different time points. The fold change is expressed as the content of metabolite in the model groups/content of metabolite in the control groups. Significant differences were based on the two-tailed t-test. Compared with the normal rats, * represents the significant differences (p < 0.05); ** represents the significant differences (p < 0.01).
a positive regulator of NF-kB which is considered to be an important transcriptional factor involved in the production of pro-inammatory cytokines. 25 In this study, the inhibition of nicotinate and nicotinamide metabolism in model rats at 2 h, 8 h and 24 h may lead to the inhibition of SIRT1, resulting in the activation of NF-kB and the elevation of inammatory cytokines as an inammatory response. Besides, the extent of inhibition of nicotinate and nicotinamide metabolism was reduced at 24 h, suggesting that the inammatory response decreased, which was consistent with the decreasing levels of IL-6, TNFa and IL-1b over time. Thus the inhibition of nicotinate and nicotinamide metabolism may be the key reason for inam-mation in THBSS. In addition, an inammatory response is rstly observed in THBSS and it may be the induction factor of abnormal hemorheology and coagulation, indicating that nicotinate and nicotinamide metabolism is the key pathway in the initiation of THBSS. The disorder of nicotinate and nicotinamide metabolism has not been reported in other blood stasis syndromes (including blood deciency and blood stasis, cold coagulation and blood stasis, etc.), so it may be the characteristic metabolic pathway of THBSS.
Energy metabolism
In this study, the levels of several glycolysis intermediates (glucose and pyruvate) and citrate cycle intermediates (isocitrate, citrate and fumarate) altered in the progression of THBSS. Compared with the normal rats, the levels of pyruvate, isocitrate and glucose increased at 2 h; citrate, isocitrate and glucose increased at 8 h; fumarate, pyruvate, isocitrate and glucose decreased at 24 h in the THBSS rats. Moreover, the content of creatinine and pyroglutamic acid reduced at 2 h and 8 h (Fig. 9 , Tables S3-S5 †) .
Glycolysis is the metabolic pathway that converts glucose into pyruvate. The free energy released in this process is used to form the high-energy molecules ATP and NADH. Pyruvate could be converted into acetyl CoA, entering the citrate cycle under aerobic conditions. The citrate cycle is the main approach for energy supply, which unies carbohydrate, fat and protein metabolism. 26 The creatine/creatine phosphate shuttle system plays an essential role in energy homeostasis. 27 Creatine kinase catalyzes the reaction of ADP with phosphocreatine to generate ATP, serving as fuel in the case of energy deciency. 28 The increase of citrate cycle intermediates (isocitrate, citrate and pyruvate) and glycolysis intermediates (pyruvate and glucose) in urine samples collected at 2 h and 8 h of THBSS rats as compared with normal rats demonstrates an activated energy metabolism. The decrease of citrate cycle intermediates (fumarate, pyruvate and isocitrate) and glycolysis intermediates (pyruvate and glucose) suggests that the energy metabolism is suppressed.
The inhibition of nicotinate and nicotinamide metabolism leads to the inammation at 2 h (the excessive heat and little blood stasis stage) and 8 h (the coexistence of heat and blood stasis stage) aer modeling, resulting in the increase of energy demand. Therefore, compared with the control group, the energy metabolism of model rats is enhanced. Moreover, it has been reported that citrate cycle intermediates are inammatory signals, 26 so the citrate cycle is regarded as the metabolic pathway related to inammation. The suppression of energy metabolism induces an insufficient supply for the heart, causing the disturbance of normal blood ow. What is worse, oxygen transport may be restrained in such a state, leading to the disturbance of energy metabolism. Eventually, the blood stasis status of model rats will not be recovered over time.
Amino acid metabolism
In this study, 23 differential amino acids involved in histidine metabolism, arginine and proline metabolism, valine, leucine and isoleucine biosynthesis, and alanine, aspartate and glutamate metabolism were found (Table S7 †) . Among them, the levels of 11 amino acids (L-lysine, proline, N-acetylornithine) decreased at 2 h and 8 h in the model group. The content of valine (branched chain amino acid) and 5-L-glutamylglycine (dipeptide) increased at 24 h in the model group. Their alterations indicate that, due to the inammation, amino acids are used for acute-phase protein synthesis, inducing the decrease of amino acids in the model group at 2 h and 8 h. 29 Besides, the elevated amino acids at 24 h suggest that protein degradation is enhanced to compensate for the clearance of amino acids.
30,31
This study also found that the content of histidine reduced at 2 h, 8 h and 24 h in the model group. Histamine converted from histidine by histidine decarboxylase can induce the expression of tissue factor. The tissue factor as the initiation factor of the extrinsic coagulation pathway has a strong procoagulant activity. 32 The change of histidine in model rats indicates that the extrinsic coagulation pathway is affected. It is consistent with the inference obtained from the blood biochemical analysis, showing that the decrease of PT resulted in the emergence of blood stasis in the later stage of THBSS. Therefore, the disorder of histidine metabolism was closely related to the aggravation of the blood stasis syndrome.
Moreover, the content of isovalerylglycine, 2-methylbutyrylglycine, and isobutyrylglycine increased at 2 h and 8 h and decreased at 24 h in the model group. It has been reported that the deciency of isovaleryl-CoA dehydrogenase, 2-methylbutyryl-CoA dehydrogenase and isobutyryl-CoA dehydrogenase involved in the valine, leucine, and isoleucine degradation leads to the increase of the excretion of isovalerylglycine, 2-methylbutyrylglycine, and isobutyrylglycine, and those enzymes can catalyze the degradation of valine, leucine and isoleucine into succinyl coenzyme A and acetyl coenzyme A to participate in the citrate cycle.
33 Therefore, the experimental results demonstrate that the activities of isovaleryl-CoA dehydrogenase, 2-methylbutyryl-CoA dehydrogenase and isobutyryl-CoA dehydrogenase are inhibited, inducing the elevation of branched chain amino acids for the synthesis of acute-phase protein. Nevertheless, at 24 h the activities of those enzymes were promoted to enhance the degradation of the branched chain amino acid into succinyl coenzyme A and acetyl coenzyme A, resulting in the enhancement of energy metabolism.
Other metabolic pathways
Taurine with favorable antioxidant activity can decrease myocardial cellular membrane damage. In addition, it can also inhibit platelet adhesion and aggregation. 34 The level of taurine in the model group at 2 h and 8 h was elevated, suggesting that the oxidative injury is serious at this time resulting in the increase of defense function. Pyruvate, as the nal product of glycolysis, is an important source of mitochondrial ATP, and is closely related to the relevant biosynthesis pathway of the citrate cycle. The disturbance of pyruvate metabolism can affect tissues with high energy demands such as myocardial tissue. 35 The content of pyruvate in the urine samples of the model rats was increased at 2 h and decreased at 24 h, demonstrating the enhancement of energy metabolism at 2 h (the excessive heat and little blood stasis stage) and the blockage of energy metabolism at 24 h (the blood stasis stage).
The nature of THSSB based on the metabonomics
Combining the metabonomic analysis and biochemistry parameters, the nature of THBSS progression was tentatively elucidated. The inhibition of nicotinate and nicotinamide metabolism leads to the inhibition of SIRT1, resulting in the inammatory response. The inammation increases the energy demand and synthesis of acute-phase proteins so that energy metabolism and amino acid metabolism are disturbed. Therefore, in the excessive heat and little blood stasis stage, the inammation cytokines (IL-6 and TNF-a) and forehead temperature are elevated signicantly; but the blood biochemical parameters (including whole blood viscosity, PT, etc.) vary slightly. As the energy is consumed, insufficient energy supply for the heart causes the disturbance of blood circulation. The alteration of several important amino acids (including histidine, homocysteine sulnic acid, etc.) also inuences the coagulation and hemorheology. Meanwhile, the inammatory response is relieved. So the coexistence of heat and blood stasis stage is manifested as the level of inammation cytokines (IL-6, IL-1b and TNF-a) and forehead temperature decreased, but the blood biochemical parameters (whole blood viscosity and APTT) increased. Furthermore, the inhibition of the nicotinate and nicotinamide metabolism alleviates. However, the abnormal blood circulation restrains the oxygen transport, leading to the inhibition of energy metabolism; the insufficient energy aggravates the disturbance of blood circulation. Therefore, the blood stasis stage shows normal levels of IL-6 and TNF-a, signicant change of blood biochemical parameters (whole blood viscosity and PT) and the most serious damage of the liver and lung (red cells clustered in the hepatic sinus and central vein of hepatic lobules, large numbers of red cells emerged in small pulmonary veins and alveolar wall capillaries, etc.) in the model group.
Conclusion
In summary, studying the metabolic network changes during syndrome progression can elucidate the scientic basis of TCM syndrome systemically and dynamically and benet the discovery of biomarkers and drug targets. Through this study, the constructed metabolic trajectories were consistent with the results of the syndrome progression diagnosed based on the TCM criterion, which showed three stages: excessive heat and little blood stasis (2-5 h), coexistence of heat and blood stasis (8-12 h) , and blood stasis (24-48 h). The mechanism of THBSS progression was that the inhibition of nicotinate and nicotinamide metabolism may lead to the activation of SIRT1 producing an inammatory response, which then resulted in the disorder of energy metabolism and amino acid metabolism, and eventually the blood stasis appeared. Among them, nicotinate and nicotinamide metabolism and histidine metabolism could be the target pathways for intervention. Nicotinate and nicotinamide metabolism might be the characteristic metabolic pathway of THBSS, which can distinguish it from other types of blood stasis syndrome. The alterations of isocitric acid, glucose, 3-dehydroxycarnitine, N-acetylglutamine, N-aacetylcitrulline, iduronic acid and homocysteine sulnic acid associated with the progression of THBSS were identied as potential biomarkers. Besides, the metabolic disturbance of the excessive heat and little blood stasis stage (2 h) and blood stasis stage (24 h) were of opposing directionality, indicating that the therapeutic Chinese medicine of THBSS probably has a bidirectional regulation mechanism, which enriches the modern connotation of the TCM theory system. The discovery of the holistic and dynamic metabolic alterations of THBSS provides a reference for clinical diagnosis and rational drug treatment of the critical diseases associated with THBSS, and it also paves a new way to elucidate the scientic basis of TCM syndrome evolution. According to the clues obtained in this study, we will further qualitatively and quantitatively determine the important metabolites and potential biomarkers. Simultaneously, we will collect clinical samples and data to verify the process and essence of THBSS.
